Iguratimod promotes transformation of mononuclear macrophages in elderly patients with rheumatoid arthritis by nuclear factor-κB pathway

Figure 4 Effects of Iguratimod on nuclear factor-κB pathway in peripheral blood mononuclear cells. A: Western blot analysis of nuclear factor-κB pathway; B: Expression of inhibitor of nuclear factor-κB (IκB) protein is the ratio of gray value of IκB to the gray value of internal reference glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and the relative expression of phosphorylated inhibitor of nuclear factor-κB (p-IκB) protein is the ratio of the gray value of p-IκB to IκB. Compared with that before treatment, ^aP < 0.05.